AB Science slides after capital increase
** Shares in AB Science ABS.PA are down 3.7% after it
announced on Monday a capital increase for 15 million euros
($16.46 million)
** The issue price of the new shares has been set at 5.75
euros
** The proceeds of the capital increase will provide the
French pharmaceutical company with the additional resources
necessary to finance its activities over the next 12 months, it
said
** The stock is on track for its worst day since mid-March
** Including today's fall the stock has dropped by 12.55%
YTD
($1 = 0.9114 euros)
(Reporting by Lina Golovnya)
((lina.golovnya@thomsonreuters.com))
Recent news on AB Science SA
See all newsBrief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041
Brief: AB Science Phase 1 AML Study Of AB8939 Shows 100% Partial Response Rate
Brief: AB Science Receives Notice Of Allowance For European Patent Covering Masitinib Until 2040 In Treatment Of Sickle Cell Disease